Touchstone
Last syncNov 1, 2026, 6:55 PM ET

SUPN

Supernus Pharmaceuticals, Inc. Health Care Pharmaceutical Preparations Russell 3000
$41.92Close $2.4BMarket cap $37.88 – $57.0052-week range Late-januaryNext report · estimated

Highlights

Cautions

  • Not in an uptrend 0 of 8 trend conditions
  • Lagging the market RS 22 · weaker than 78% of stocks over 12 months
  • Far from its high 26% below its 52-week high

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Oct 29, 2026
Off 12-month high 26%
1wk up 3.0% price change
1mo down 2.6% price change
12-month return down 26% market up 11% · its own down 36%
F-score 5 / 9 Mixed
Altman Z 4.80 Low risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B 2.3× price / book
Earnings yield down 2.7% EBIT / enterprise value
Cheaper than 39% of the market · expensive
Revenue growth up 9% year on year
EPS growth — latest quarter
Sales growth up 18% latest quarter · -14 pts
ROE down 4% return on equity
Free cash margin up 6% $46.0M FCF
D/E — long-term debt / equity
Net debt / EBITDA -4.4× net cash
Interest cover —EBIT / interest
Piotroski tests
  • not yet profitable on its assets
  • profitability slipped from last year
  • short-term liquidity weakened
  • issued more shares
  • generating cash from operations
  • profits backed by cash
  • reduced long-term debt
  • gross margin widened
  • assets working harder

Repair signals

  • Gross margin 88.2% → 89.6%

Trade setup

ATR% 4.6% $1.94 a day · 2×ATR $38.05
RS 22 / 99 vs the universe
Trend 0 / 8 trend template
Relative volume 3.6× vs 50-day average
Up/down volume 1.06 50 sessions
Implied move — no scheduled report
Trend template · 0 of 8

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Shareholders diluted The share count rose 3.1% over the year, from 56m to 57m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported Oct 29, 2026
Results reaction Oct 29, 2026+4% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $719.0M +9% on FY2024
$0 $1B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $520.4M FY2021 · $579.8M FY2022 · $667.2M FY2023 · $607.5M FY2024 · $661.8M FY2025 · $719.0M
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$38.6M down to a loss
-$50M $0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $127.0M FY2021 · $53.4M FY2022 · $60.7M FY2023 · $1.3M FY2024 · $73.9M FY2025 · -$38.6M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $46.0M -73% on FY2024
$0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $134.9M FY2021 · $127.1M FY2022 · $116.4M FY2023 · $110.5M FY2024 · $171.2M FY2025 · $46.0M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 90%
  • Net -5%
  • Free cash 6%
0% 100% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 90% · Net 24% · Free cash 26% FY2021 · Net 9% · Free cash 22% FY2022 · Gross 87% · Net 9% · Free cash 17% FY2023 · Gross 86% · Net 0% · Free cash 18% FY2024 · Gross 88% · Net 11% · Free cash 26% FY2025 · Gross 90% · Net -5% · Free cash 6%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology
  • Cash
  • Long-term debt
$0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $288.6M FY2021 · Cash $203.4M · Long-term debt $379.3M FY2022 · Cash $93.1M FY2023 · Cash $75.1M FY2024 · Cash $69.3M FY2025 · Cash $128.4M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 57.46m +8.7% since FY2020
57.46m 52.87m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 52.87m FY2021 · 53.26m FY2022 · 54.25m FY2023 · 54.72m FY2024 · 55.74m FY2025 · 57.46m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $520.4M $579.8M $667.2M $607.5M $661.8M $719.0M
Gross margin 90% — 87% 86% 88% 90%
Operating income $173.7M $86.0M $46.1M -$5.3M $81.7M -$62.3M
Net income $127.0M $53.4M $60.7M $1.3M $73.9M -$38.6M
Net margin 24% 9% 9% 0% 11% -5%
Earnings per share $2.36 $0.98 $0.98 $0.02 $1.32 -$0.68
Free cash flow $134.9M $127.1M $116.4M $110.5M $171.2M $46.0M
Free cash margin 26% 22% 17% 18% 26% 6%
Cash $288.6M $203.4M $93.1M $75.1M $69.3M $128.4M
Long-term debt — $379.3M — — — —
Shareholders' equity $744.9M $815.9M $886.2M $921.5M $1.0B $1.1B
Shares outstanding 52.87m 53.26m 54.25m 54.72m 55.74m 57.46m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Oct 29, 2026 Quarterly ↗ Sep 30, 2026 29d
Aug 3, 2026 Quarterly ↗ Jun 30, 2026 34d
May 5, 2026 Quarterly ↗ Mar 31, 2026 35d
Mar 2, 2026 Annual ↗ Dec 31, 2025 61d
Nov 6, 2025 Quarterly ↗ Sep 30, 2025 37d
Aug 5, 2025 Quarterly ↗ Jun 30, 2025 36d
May 6, 2025 Quarterly ↗ Mar 31, 2025 36d
Feb 25, 2025 Annual ↗ Dec 31, 2024 56d
Nov 4, 2024 Quarterly ↗ Sep 30, 2024 35d
Aug 6, 2024 Quarterly ↗ Jun 30, 2024 37d
May 8, 2024 Quarterly ↗ Mar 31, 2024 38d
Nov 8, 2023 Quarterly ↗ Sep 30, 2023 39d

Current reports

FiledDisclosed
Oct 29, 2026 Results ↗
Oct 26, 2026 Agreement ended ↗
Oct 22, 2026 Other events ↗
Oct 19, 2026 Results ↗
Oct 15, 2026 Shareholder vote ↗
Aug 3, 2026 Results ↗
Aug 3, 2026 Other events ↗
Aug 3, 2026 Other events ↗
Aug 3, 2026 Material agreement · Director or officer change · Other events ↗
Jul 22, 2026 Results ↗
Jun 18, 2026 Shareholder vote ↗
May 20, 2026 New obligation ↗